Antinuclear Antibody (ANA), Body Fluid
Antinuclear antibodies (ANA) are a group of antibodies directed against various nuclear and some cytoplasmic cell antigens including dsDNA, ssDNA, RNP, Sm, SSA, and SSB. Antinuclear Antibodies are frequently observed in patients with autoimmune diseases, most commonly systemic lupus erythematosus (SLE). Positive ANAs may also be seen in other autoimmune diseases, including rheumatoid arthritis, collagen vascular diseases, chronic liver diseases, systemic sclerosis (scleroderma), Sjögren’s syndrome, and polymyositis/dermatomyositis. Immunoassay screening tests for ANAs are widely used and may be followed by a series of more specific markers that will help in the differential diagnosis of autoimmune diseases and/or disorders.
Immunoassay screening using enriched HEP-2 cell extracts has led to improved sensitivity compared to historical immunofluorescence methods. Because of the multi-antigenic nature of the test, false positive test results may occur in apparently healthy individuals; therefore, patients should be evaluated in consideration of complete physical presentation. Additional laboratory testing can be considered to confirm and evaluate positive screen results. Options available are Immunofluorescence Assay (IFA) testing or antigen specific cascades to evaluate specificity.
Aids in diagnosis of various autoimmune diseases such as:
- Systemic Lupus Erythematosus
- Mixed Connective Tissue Disease
- Dermatomyositis
- Polymyositis
- Rheumatoid Arthritis
- CREST Syndrome
- Sjögren’s syndrome
- Collagen vascular diseases
Elevated in:
- Autoimmune diseases such as systemic lupus erythematosus (SLE) Discoid lupus and drug-induced lupus
- Sjögren’s syndrome
- Rheumatoid arthritis
- Scleroderma
- Mixed connective tissue disease
- Dermatomyositis
- Polymyositis
- Also increased in liver cirrhosis, hepatitis, leukemia, myasthenia gravis, chronic renal failure, infectious mononucleosis
Note: This is a screening test and its specificity is very low. Patients over age 65 or pregnant women might have a positive (usually low titers) ANA screen with no underlying autoimmune disease.
Negative (Non-reactive)
If semiquantitative: <0.9 index value
Serum (SST)
Stability
- Ambient: 48 hours
- Refrigerated: 7 days
- Frozen: 60 days
- Rinsho Byori. 2005 Jun;53(6):562-9. [PMID: 16026086]
- Scand J Rheumatol. 2005 Jul-Aug;34(4):260-8. [PMID: 16195158]
- Clin Immunol Immunopathol. 1998 Sep;88(3):211-20. [PMID: 9743606]
- J Rheumatol. 2005 Sep;32(9):1643-9. [PMID: 16142854]
- Arch Pathol Lab Med. 1998 Nov;122(11):993-9. [PMID: 9822128]
- Autoimmun Rev. 2008 Sep;7(8):588-93. [PMID: 18617021]
- Am J Clin Pathol. 2002;117:316. [PMID: 11863229]
- J Nephrol. 2002 Nov-Dec;15 Suppl 6:S20-7. [PMID: 12515370]
- Scand J Immunol. 2006;64:227. [PMID: 16918691]
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757